The impact of amaranth oil supplementation on the expression of early markers of atherosclerosis in overweight and obese patients - randomized nutritional study
Not Applicable
- Conditions
- I70E66AtherosclerosisObesity
- Registration Number
- DRKS00014046
- Lead Sponsor
- Department of Pediatric Gastroenterology and Metabolic DiseasesPoznan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
BMI greater than or equal to 25
Exclusion Criteria
history of chronic systemic disease,
celiac disease,
liver disease,
exocrine pancreatic insufficiency,
current or recent (within preceding month) treatment with conjugated linoleic acid
current treatment with agents interfering with fat digestion/absorption (chitosan, orlistat, green tea).
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method